Filing Details

Accession Number:
0001562180-19-004440
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-22 16:40:40
Reporting Period:
2019-08-20
Accepted Time:
2019-08-22 16:40:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459839 Si-Bone Inc. SIBN Surgical & Medical Instruments & Apparatus (3841) 262216351
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755111 Carlton W Reckling C/O Si-Bone, Inc.
471 El Camino Real, Suite 101
Santa Clara CA 95050
Cmo And Vp, Medical Affairs No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-20 3,930 $3.96 13,826 No 4 M Direct
Common Stock Disposition 2019-08-20 3,930 $20.01 9,896 No 4 S Direct
Common Stock Acquisiton 2019-08-21 770 $3.96 10,666 No 4 M Direct
Common Stock Disposition 2019-08-21 770 $20.03 9,896 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-20 3,930 $0.00 3,930 $3.96
Common Stock Stock Option (Right to Buy) Disposition 2019-08-21 770 $0.00 770 $3.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,324 2023-03-18 No 4 M Direct
45,554 2023-03-18 No 4 M Direct
Footnotes
  1. Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
  2. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
  3. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.11, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  4. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.18, inclusive.
  5. The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.